Meijuan Chen
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 5
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 4
- Advanced biosensing and bioanalysis techniques 4
-
- Electrospun Nanofibers in Biomedical Applications 7
-
- Autophagy in Disease and Therapy 5
-
- Ferroptosis and cancer prognosis 4
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Xu ZhangJing ZhouXiaoxia WangHaian FuCheng HuRilei JiangYuanyuan GuoRuolin Zhao
- Journals
- Carbohydrate Polymers (2 papers)Biosensors and Bioelectronics (2 papers)Organic Letters (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Meijuan Chen
58 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 242
- Complementary and alternative medicine 100
- Pharmacology 105
- Molecular Biology 813
- Immunology 153
Countries citing papers authored by Meijuan Chen
This map shows the geographic impact of Meijuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meijuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meijuan Chen more than expected).
Fields of papers citing papers by Meijuan Chen
This network shows the impact of papers produced by Meijuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meijuan Chen. The network helps show where Meijuan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meijuan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 18 | |
| 12 | 2022 | 38 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 27 | |
| 16 | 2020 | 11 | |
| 17 | 2020 | 30 | |
| 18 | 2019 | 23 | |
| 19 | 2015 | 108 | |
| 20 | 2012 | 70 |
About Meijuan Chen
Meijuan Chen is a scholar working on Pharmacology, Cancer Research and Biomaterials, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (7 papers), Cancer-related molecular mechanisms research (7 papers), Pharmacological Effects of Natural Compounds (5 papers), Autophagy in Disease and Therapy (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (242 citations), Complementary and alternative medicine (100 citations) and Pharmacology (105 citations). Meijuan Chen has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xu Zhang, Jing Zhou, Xiaoxia Wang, Haian Fu, Cheng Hu, Rilei Jiang, Yuanyuan Guo, Ruolin Zhao, Miao Jiang and Zequn Jiang. Their work appears in journals such as Carbohydrate Polymers, Biosensors and Bioelectronics and Organic Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.